Choroid plexus controls brain availability of anti-HIV nucleoside analogs via pharmacologically inhibitable organic anion transporters

No abstract is available for this paper.

• Publication year

  2003

• Venue

  AIDS (London)

• Publication date

  2003-07-04

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/00002030-200307040-00008PMID 12824785
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human organic anion transporters and human organic cation transporters mediate renal antiviral transport.

  2002cited by this paper
• Choroid Plexus Transporters for Drugs and Other Xenobiotics

  2002cited by this paper
• Expression and functional characterization of rat organic anion transporter 3 (rOat3) in the choroid plexus.

  2002cited by this paper
• Transport characteristics of the anti-human immunodeficiency virus nucleoside analog, abacavir, into brain and cerebrospinal fluid.

  2001cited by this paper
• Transport of antiviral 3'-deoxy-nucleoside drugs by recombinant human and rat equilibrative, nitrobenzylthioinosine (NBMPR)-insensitive (ENT2) nucleoside transporter proteins produced in Xenopus oocytes.

  2001cited by this paper
• Brain drug delivery, drug metabolism, and multidrug resistance at the choroid plexus

  2001cited by this paper
• Organic anion transport across the choroid plexus

  2001cited by this paper
• HIV-1 reverse transcriptase sequence in plasma and cerebrospinal fluid of patients with AIDS dementia complex treated with Abacavir

  2001cited by this paper
• Choroid Plexus in the Central Nervous System: Biology and Physiopathology

  2000cited by this paper
• Analysis of human immunodeficiency virus type 1 gp160 sequences from a patient with HIV dementia: evidence for monocyte trafficking into brain.

  2000cited by this paper
• HIV and HIV dementia.

  2000cited by this paper
• Organization of choroid plexus epithelial and endothelial cell tight junctions and regulation of claudin‐1, ‐2 and ‐5 expression by protein kinase C

  2000cited by this paper
• Rat multispecific organic anion transporter 1 (rOAT1) transports zidovudine, acyclovir, and other antiviral nucleoside analogs.

  2000cited by this paper
• Comparisons of HIV-1 viral sequences in brain, choroid plexus and spleen: potential role of choroid plexus in the pathogenesis of HIV encephalitis.

  2000cited by this paper
• Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid

  2000cited by this paper
• The multispecific organic anion transporter (OAT) family

  2000cited by this paper
• Pharmacokinetics of [14C]Abacavir, a Human Immunodeficiency Virus Type 1 (HIV-1) Reverse Transcriptase Inhibitor, Administered in a Single Oral Dose to HIV-1-Infected Adults: a Mass Balance Study

  1999cited by this paper
• ddC- and 3TC-bis(SATE) monophosphate prodrugs overcome cellular resistance mechanisms to HIV-1 associated with cytidine kinase deficiency.

  1999cited by this paper
• Mechanisms of transport of nucleosides and nucleoside analogues in choroid plexus.

  1999cited by this paper
• Demonstration of a Coupled Metabolism–Efflux Process at the Choroid Plexus as a Mechanism of Brain Protection Toward Xenobiotics

  1999cited by this paper
• Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood-cerebrospinal-fluid drug-permeability barrier.

  1999cited by this paper
• Occludin and claudins in tight-junction strands: leading or supporting players?

  1999cited by this paper
• Mechanism of Organic Anion Transport across the Apical Membrane of Choroid Plexus*

  1999cited by this paper
• High human immunodeficiency virus type 1 RNA load in the cerebrospinal fluid from patients with lymphocytic meningitis.

  1998cited by this paper
• Neurological complications of HIV infection.

  1998cited by this paper
• Cerebrospinal fluid HIV‐1 RNA levels: correlation with HIV encephalitis

  1998cited by this paper
• HIV and HIV dementia.

  1998cited by this paper
• Cerebrospinal fluid mononuclear cell counts influence CSF HIV-1 RNA levels.

  1998cited by this paper
• Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine.

  1998cited by this paper
• In vivo evidence of HIV-1 productive infection in cerebrospinal fluid of patients with HIV-1 encephalopathy.

  1997cited by this paper
• HIV infection of macrophages and pathogenesis of AIDS dementia complex: interaction of the host cell and viral genotype

  1997cited by this paper
• The entry of antiviral and antiretroviral drugs into the central nervous system.

  1997cited by this paper
• In vivo evidence of HIV-1 productive infection in cerebrospinal fluid of patients with HIV-1 encephalitis.

  1997cited by this paper
• Role of efflux transport across the blood-brain barrier and blood-cerebrospinal fluid barrier on the disposition of xenobiotics in the central nervous system☆

  1997cited by this paper
• The passage of azidodeoxythymidine into and within the central nervous system: does it follow the parent compound, thymidine?

  1997cited by this paper
• 1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activity

  1997cited by this paper
• Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage.

  1997cited by this paper
• Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome

  1997cited by this paper
• Distributed model analysis of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine distribution in brain tissue and cerebrospinal fluid.

  1997cited by this paper
• Absorption and elimination kinetics of zidovudine in the cerebrospinal fluid in HIV-1-infected patients.

  1997cited by this paper
• Investigation of the dynamics of the spread of human immunodeficiency virus to brain and other tissues by evolutionary analysis of sequences from the p17gag and env genes

  1997cited by this paper
• Cellular reservoirs of HIV‐1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry

  1996cited by this paper
• Rapid distribution of intraventricularly administered sucrose into cerebrospinal fluid cisterns via subarachnoid velae in rat.

  1996cited by this paper
• Neuropathology of Early HIV‐1 Infection

  1996cited by this paper
• Evaluation of human immunodeficiency virus (HIV) type 1 RNA levels in cerebrospinal fluid and viral resistance to zidovudine in children with HIV encephalopathy.

  1996cited by this paper
• Neurological complications of HIV infection.

  1996cited by this paper
• Physiology of the CSF and Blood-Brain Barriers

  1996influential reference
• Pharmacokinetics of lamivudine and BCH-189 in plasma and cerebrospinal fluid of nonhuman primates

  1995cited by this paper
• Concise overview of the clinical pharmacokinetics of dideoxynucleoside antiretroviral agents

  1995cited by this paper
• Zidovudine transport in the rabbit brain during intravenous and intracerebroventricular infusion.

  1995cited by this paper
• HIV Infection of Human Choroid Plexus: A Possible Mechanism of Viral Entry into the CNS

  1995cited by this paper
• Human immunodeficiency virus type 1 infection of the brain

  1993cited by this paper
• Early viral brain invasion in iatrogenic human immunodeficiency virus infection

  1992cited by this paper
• Pharmacokinetics of 3'-azido-3'-deoxythymidine and its catabolites and interactions with probenecid in rhesus monkeys

  1991cited by this paper
• Probenecid Inhibits the Metabolic and Renal Clearances of Zidovudine (AZT) in Human Volunteers

  1990cited by this paper
• Brain and cerebrospinal fluid uptake of zidovudine (AZT) in rats after intravenous injection.

  1990cited by this paper
• Zidovudine with probenecid: a warning.

  1990cited by this paper
• Human choroid plexus cells can be latently infected with human immunodeficiency virus

  1989cited by this paper
• Pharmacology of the Blood-Brain Barrier

  1989cited by this paper
• Effect of probenecid on the renal and nonrenal clearances of zidovudine and its distribution into cerebrospinal fluid in the rabbit.

  1989cited by this paper
• Implications of the Blood-Brain Barrier and Its Manipulation

  1989cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• 3'-azido-3'-deoxythymidine. An unusual nucleoside analogue that permeates the membrane of human erythrocytes and lymphocytes by nonfacilitated diffusion.

  1987cited by this paper
• Molecular sieving characteristics of the cultured endothelial monolayer

  1987cited by this paper
• Evidence for a 'paravascular' fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space.

  1985cited by this paper
• Permeability of the choroid plexus of the rabbit to several solutes.

  1966influential reference

• Molecular determinants of neuroprotection in blood-brain interfaces of the cynomolgus monkey

  2025cites this paper
• Modeling Infectious Diseases of the Central Nervous System with Human Brain Organoids.

  2022cites this paper
• In Vitro Models of the Blood–Cerebrospinal Fluid Barrier and Their Applications in the Development and Research of (Neuro)Pharmaceuticals

  2022cites this paper
• Recent Advancements in Nanodiamond Mediated Brain Targeted Drug Delivery and Bioimaging of Brain Ailments: A Holistic Review.

  2021cites this paper
• Blood–Brain Barrier Transporters and Central Nervous System Drug Response and Toxicity

  2021cites this paper
• N-acetylcysteine inhibits bacterial lipopeptide-mediated neutrophil transmigration through the choroid plexus in the developing brain

  2020cites this paper
• Bile salt-coating modulates the macrophage uptake of nanocores constituted by a zidovudine prodrug and enhances its nose-to-brain delivery.

  2019cites this paper
• Mécanismes de neuroprotection liés au glutathion dans la barrière sang - liquide céphalorachidien choroïdienne au cours du développement périnatal

  2019cites this paper
• Glutathione Conjugation at the Blood–CSF Barrier Efficiently Prevents Exposure of the Developing Brain Fluid Environment to Blood-Borne Reactive Electrophilic Substances

  2018cites this paper
• Neuropharmacology.

  2018cites this paper
• Choroid plexus glutathione peroxidases are instrumental in protecting the brain fluid environment from hydroperoxides during postnatal development.

  2018influential citation
• Repositioning of drugs using open-access data portal DTome: A test case with probenecid (Review).

  2016cites this paper
• Towards longitudinal mapping of extracellular pH in gliomas

  2016cites this paper
• Polysaccharides as drug delivery systems for different administration routes

  2016influential citation
• Role and modulation of drug transporters in HIV-1 therapy.

  2016cites this paper
• T-Lymphocytes Traffic into the Brain across the Blood-CSF Barrier: Evidence Using a Reconstituted Choroid Plexus Epithelium

  2016cites this paper
• Modeling immune functions of the mouse blood–cerebrospinal fluid barrier in vitro: primary rather than immortalized mouse choroid plexus epithelial cells are suited to study immune cell migration across this brain barrier

  2015cites this paper
• Novel routes to either racemic or enantiopure α-amino-(4-hydroxy-pyrrolidin-3-yl)acetic acid derivatives and biological evaluation of a new promising pharmacological scaffold.

  2015cites this paper
• Efflux transporters in blood-brain interfaces of the developing brain

  2015influential citation
• The choroid plexus—a multi-role player during infectious diseases of the CNS

  2015cites this paper
• Characterizing the Expression and Localization of Drug Transporters and Metabolic Enzymes in the testes of Uninfected and HIV-1 Infected, Treated Subjects – Potential Contribution to an HIV-1 Sanctuary

  2015cites this paper
• Nasal chitosan microparticles target a zidovudine prodrug to brain HIV sanctuaries.

  2015cites this paper
• Role of CNS transporters in the pharmacotherapy of HIV-1 associated neurological disorders.

  2014cites this paper
• Neurologic disease in HIV‐infected children and the impact of combination antiretroviral therapy

  2014cites this paper
• Brain uptake of a Zidovudine prodrug after nasal administration of solid lipid microparticles.

  2014cites this paper
• Biology and Regulation of Blood-Tissue Barriers

  2014cites this paper
• Functional and genetic analysis of choroid plexus development in zebrafish

  2014cites this paper
• Therapeutic drug monitoring of intracellular anti-infective agents.

  2014cites this paper
• Drug Metabolism at the Blood–Brain and Blood–CSF Barriers

  2014cites this paper
• Physiology of blood-brain interfaces in relation to brain disposition of small compounds and macromolecules.

  2013cites this paper
• Developmental changes in the transcriptome of the rat choroid plexus in relation to neuroprotection

  2013cites this paper
• Organic anion transport pathways in antiviral handling in choroid plexus in Oat1 (Slc22a6) and Oat3 (Slc22a8) deficient tissue.

  2013cites this paper
• Drug Transporters At Brain Barriers

  2013cites this paper
• Zidovudine and ursodeoxycholic acid conjugation: design of a new prodrug potentially able to bypass the active efflux transport systems of the central nervous system.

  2012cites this paper
• Targeting choroid plexus epithelia and ventricular ependyma for drug delivery to the central nervous system

  2011cites this paper
• Modulation of Mrp1 (ABCc1) and Pgp (ABCb1) by Bilirubin at the Blood-CSF and Blood-Brain Barriers in the Gunn Rat

  2011cites this paper
• Active transport at the blood‐CSF barrier contributes to manganese influx into the brain

  2011cites this paper
• The blood-cerebrospinal fluid barrier: structure and functional significance.

  2011cites this paper
• In Vitro Models of the Blood–Cerebrospinal Fluid Barrier and Their Use in Neurotoxicological Research

  2011cites this paper
• Title Targeting choroid plexus epithelia and ventricular ependyma for drug delivery to the central nervous system

  2011cites this paper
• Drug uptake transporters in antiretroviral therapy.

  2011cites this paper
• Derivation of primary choroid plexus epithelial cells from the mouse.

  2010cites this paper
• Expression and functional activity of nucleoside transporters in human choroid plexus

  2010cites this paper
• Intracellular Pharmacokinetics of Antiretroviral Drugs in HIV-Infected Patients, and their Correlation with Drug Action

  2010cites this paper
• The transport of anti-HIV drugs across blood–CNS interfaces: Summary of current knowledge and recommendations for further research

  2009influential citation
• Blood-brain interfaces and bilirubin-induced neurological diseases.

  2009cites this paper
• The Changing Face of HIV-Associated Cognitive and Neuropsychiatric Disturbance

  2009cites this paper
• Blood-brain interfaces and cerebral drug bioavailability.

  2009cites this paper
• Use of Z310 cells as an in vitro blood-cerebrospinal fluid barrier model: tight junction proteins and transport properties.

  2008cites this paper
• Effect of bilirubin on expression and localization of PGP and Mrp1 in the central nervous system

  2008cites this paper
• Brain Protection at the Blood–Cerebrospinal Fluid Interface Involves a Glutathione-Dependent Metabolic Barrier Mechanism

  2006cites this paper
• Toxic shock syndrome toxin-1 challenges the neuroprotective functions of the choroidal epithelium and induces neurotoxicity.

  2006cites this paper
• Molecular and Functional Analyses of Transport Proteins for Organic Anions

  2006cites this paper
• Factors affecting delivery of antiviral drugs to the brain

  2005influential citation
• EUFEPS conference on drug transporters at Copenhagen: integrative approaches in ADME research.

  2005cites this paper
• Choroid Plexus and Drug Therapy for AIDS Encephalopathy

  2005cites this paper
• Impairment of blood–cerebrospinal fluid barrier properties by retrovirus‐activated T lymphocytes: reduction in cerebrospinal fluid‐to‐blood efflux of prostaglandin E2

  2005cites this paper
• Enhanced Prospects for Drug Delivery and Brain Targeting by the Choroid Plexus–CSF Route

  2005cites this paper
• In Vitro Investigation of the Blood‚ÄìCerebrospinal Fluid Barrier Properties: Primary Cultures and Immortalized Cell Lines of the Choroidal Epithelium

  2005cites this paper
• Detoxification systems, passive and specific transport for drugs at the blood-CSF barrier in normal and pathological situations.

  2004cites this paper
• Interaction of Nucleoside Analogues with Nucleoside Transporters in Rat Brain Endothelial Cells

  2004cites this paper
• Efflux transport systems for organic anions and cations at the blood-CSF barrier.

  2004cites this paper
• Anti-HIV drug distribution to the central nervous system.

  2004cites this paper
• Involvement of rat organic anion transporter 3 in the uptake of an organic herbicide, 2,4-dichlorophenoxyacetate, by the isolated rat choroid plexus.

  2004cites this paper
• Carrier-mediated uptake of H2-receptor antagonists by the rat choroid plexus: involvement of rat organic anion transporter 3.

  2004cites this paper
• Pro‐Inflammatory Cytokines Modulate Matrix Metalloproteinase Secretion and Organic Anion Transport at the Blood‐Cerebrospinal Fluid Barrier

  2003cites this paper
• Atp Binding Cassette Multidrug Transporters Limit the Anti-HIV Activity of Zidovudine and Indinavir in Infected Human Macrophages

  2003cites this paper